Key result
Aldosterone and spironolactone in the context of heart failure are discussed in this article, which does not report quantitative primary study results.
Authors
Loading...
No new quantitative results on aldosterone antagonists in HF; leaves open need for updated outcome trials in contemporary cohorts.
Karl T. Weber (1999) conducted a review in Heart Failure. Aldosterone and Spironolactone was evaluated. Aldosterone and spironolactone in the context of heart failure are discussed in this article, which does not report quantitative primary study results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: